flecainide has been researched along with Emesis in 2 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonilla-Palomas, JL | 1 |
López-López, JM | 1 |
Moreno-Conde, M | 1 |
Gallego de la Sacristana, A | 1 |
Gámez-López, AL | 1 |
Villar-Ráez, A | 1 |
Köppel, C | 1 |
Oberdisse, U | 1 |
Heinemeyer, G | 1 |
2 other studies available for flecainide and Emesis
Article | Year |
---|---|
Type I Brugada electrocardiogram pattern induced by metoclopramide.
Topics: Brugada Syndrome; Dizziness; Dopamine Antagonists; Flecainide; Humans; Male; Metoclopramide; Middle | 2011 |
Clinical course and outcome in class IC antiarrhythmic overdose.
Topics: Ajmaline; Anti-Arrhythmia Agents; Bicarbonates; Bradycardia; Drug Overdose; Flecainide; Hemoperfusio | 1990 |